WARNER-LAMBERT ACCUPRIL SALES UP 37% TO $312 MIL., LEADING Rx SALES GROWTH IN 1995; CARDINAL REPORTS SUBSTANTIALLY IMPROVED GROSS MARGINS
Executive Summary
Warner-Lambert's 1995 pharmaceutical sales were fueled by growth from the ACE inhibitor Accupril, which posted a sales gain of 37% and full-year revenues of $312 mil. Warner-Lambert reported Jan. 23 that overall 1995 sales worldwide increased 10% to $7.04 bil. Sales for the year included a 7% unit volume gain, the company noted. Earnings for the year increased 7% to $740 mil. and included a third quarter, pre-tax charge of $117 mil. from the sale of the PRO toothbrush business.